Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
about
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
description
clinical trial
@en
klinisch onderzoek
@nl
name
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
@en
type
label
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
@en
prefLabel
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
@en
P1476
Phase 1 Dose-escalation Study ...... ransdermally Accessible Tumour
@en
P3098
NCT01058616
P580
2010-01-01T00:00:00Z
P582
2013-01-01T00:00:00Z